Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

NCT01704781 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Lenalidomide
DRUG: Lenalidomide placebo
DRUG: Vacc-4X
DRUG: rhuGM-CSF

Sponsor

Bionor Immuno AS

Collaborators

[object Object]